CLOV
Clover Health Investments, Corp. /DeCompany with tickers: CLOV
CIK
1801170
CUSIP
18914F103
Shares Outstanding
430,969,398
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $462,331,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $463,605,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Research & Development | — | ||||
| Operating Income | $-1,274,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| Net Income | $-1,274,000 | USD | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Basic) | $0.00 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |
| EPS (Diluted) | $0.00 | USD/shares | 2025-03-31 | 10-Q | 2026-05-08 |